{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T18:09:35Z","timestamp":1767204575762,"version":"build-2238731810"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Plasmacytoid dendritic cells (pDCs) are multifunctional immune cells with roles in both the innate and adaptive immune system. Their hallmark function is production of large amounts of type I interferons in response to viral infections, but they are also capable of producing a range of other cytokines, antigen presentation, and cytotoxicity. Their potential as an immunotherapy for cancer and infectious disease is being explored, but broad application of these cells is challenged by low frequency in the blood and low viability during\n                    <jats:italic>ex vivo<\/jats:italic>\n                    culturing. We have previously developed an effective\n                    <jats:italic>in vitro<\/jats:italic>\n                    differentiation protocol for producing pDCs from CD34+ hematopoietic stem and progenitor cells (HSPC-pDCs), which provides an attainable and large source of pDCs. HSPC-pDCs present pDC characteristics and functions, and like naturally occurring pDCs they exhibit large phenotypic and functional heterogeneity. Here, we characterize different cell subsets from\n                    <jats:italic>in vitro<\/jats:italic>\n                    pDC differentiation and identify a distinct population, which is the major producer of IFN\u03b1 in response to TLR9 stimulation and display a transcriptomic profile similar to what is seen for pDCs circulating in the blood. We also investigate the possibility of rerouting subset specification during HSPCs-to-pDC differentiation by controlling gene expression of key master transcription factors (TFs). We identify TFs associated with the pDC differentiation trajectory that are essential for the development of TLR9-responsive HSPC-pDCs, and we also identify TFs that increase their frequency. In conclusion, we phenotypically and functionally characterize different cell subsets and modulate their relative frequencies by manipulating TF expression during pDC differentiation. These findings provide a deeper understanding of\n                    <jats:italic>in vitro<\/jats:italic>\n                    -differentiated pDC cultures that may spur further developments in their use as an immunomodulatory cell therapy.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2025.1550397","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T22:18:53Z","timestamp":1743113933000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of TLR9 responsiveness in cell subsets derived from in vitro pDC differentiation of hematopoietic stem and progenitor cells"],"prefix":"10.3389","volume":"16","author":[{"given":"Sabina","family":"S\u00e1nchez Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias Wang","family":"Bjerg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian Helstrup","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Laustsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Q Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars Henning","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eynav","family":"Klechevsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin R.","family":"Jakobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasmus O.","family":"Bak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5421.1835","article-title":"The nature of the principal type 1 interferon-producing cells in human blood","volume":"284","author":"Siegal","year":"1999","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/11360","article-title":"Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon","volume":"5","author":"Cella","year":"1999","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.immuni.2018.12.027","article-title":"Plasmacytoid dendritic cells: development, regulation, and function","volume":"50","author":"Reizis","year":"2019","journal-title":"Immunity"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01167-5","article-title":"The role of plasmacytoid dendritic cells (pDCs) in immunity during viral infections and beyond","volume":"21","author":"Ngo","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1602","article-title":"Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I","volume":"9","author":"Di Pucchio","year":"2008","journal-title":"Nat Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2583","article-title":"Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients","volume":"73","author":"Tel","year":"2013","journal-title":"Cancer Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s40425-019-0787-6","article-title":"Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer","volume":"7","author":"Westdorp","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1738812","DOI":"10.1080\/2162402X.2020.1738812","article-title":"An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial","volume":"9","author":"Charles","year":"2020","journal-title":"Oncoimmunology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4711","article-title":"Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients","volume":"14","author":"Molenkamp","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0050","article-title":"Intradermal CpG-B activates both plasmacytoid and myeloid dendritic cells in the sentinel lymph node of melanoma patients","volume":"13","author":"Molenkamp","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13046-024-03121-9","article-title":"Plasmacytoid dendritic cells at the forefront of anti-cancer immunity: rewiring strategies for tumor microenvironment remodeling","volume":"43","author":"Monti","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1360291","article-title":"Inhibitory receptors of plasmacytoid dendritic cells as possible targets for checkpoint blockade in cancer","volume":"15","author":"Tiberio","year":"2024","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911397","article-title":"Plasmacytoid dendritic cells as a novel cell-based cancer immunotherapy","volume":"23","author":"Hernandez","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1038\/s41467-018-05816-y","article-title":"Interferon priming is essential for human CD34+ cell-derived plasmacytoid dendritic cell maturation and function","volume":"9","author":"Laustsen","year":"2018","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.65528.sa2","article-title":"Ascorbic acid supports ex vivo generation of plasmacytoid dendritic cells from circulating hematopoietic stem cells","volume":"10","author":"Laustsen","year":"2021","journal-title":"Elife"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021109622","article-title":"TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection","volume":"41","author":"van der Sluis","year":"2022","journal-title":"EMBO J"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2015.116","article-title":"A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subset","volume":"94","author":"Bryant","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0802008","article-title":"CD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions","volume":"182","author":"Matsui","year":"2009","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41590-017-0012-z","article-title":"Diversification of human plasmacytoid predendritic cells in response to a single stimulus","volume":"19","author":"Alculumbre","year":"2018","journal-title":"Nat Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201387","article-title":"SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4","volume":"218","author":"Onodi","year":"2021","journal-title":"J Exp Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1038\/s41467-018-05784-3","article-title":"Single-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cells","volume":"9","author":"Wimmers","year":"2018","journal-title":"Nat Commun"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.814627","article-title":"Proteomic and single-cell transcriptomic dissection of human plasmacytoid dendritic cell response to influenza virus","volume":"13","author":"Ghanem","year":"2022","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"107628","DOI":"10.1016\/j.isci.2023.107628","article-title":"Single cell analysis reveals a subset of cytotoxic-like plasmacytoid dendritic cells in people with HIV-1","volume":"26","author":"Cham","year":"2023","journal-title":"iScience"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1433119","article-title":"Human CD34(+)-derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy","volume":"15","author":"Fiore","year":"2024","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2008.09.016","article-title":"Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development","volume":"135","author":"Cisse","year":"2008","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.molimm.2022.05.009","article-title":"Regulation and function of Id2 in plasmacytoid dendritic cells","volume":"148","author":"Babcock","year":"2022","journal-title":"Mol Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130443","article-title":"Transcription factor Runx2 controls the development and migration of plasmacytoid dendritic cells","volume":"210","author":"Sawai","year":"2013","journal-title":"J Exp Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.immuni.2018.11.010","article-title":"Transcription factor PU.1 promotes conventional dendritic cell identity and function via induction of transcriptional regulator DC-SCRIPT","volume":"50","author":"Chopin","year":"2019","journal-title":"Immunity"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aai7677","article-title":"Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironment","volume":"1","author":"Heidkamp","year":"2016","journal-title":"Sci Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0145-8","article-title":"Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific","volume":"19","author":"Michea","year":"2018","journal-title":"Nat Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah4573","article-title":"Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors","volume":"356","author":"Villani","year":"2017","journal-title":"Science"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838470","article-title":"Development of human plasmacytoid dendritic cells depends on the combined action of the basic helix-loop-helix factor E2-2 and the Ets factor Spi-B","volume":"38","author":"Nagasawa","year":"2008","journal-title":"Eur J Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.24273","article-title":"Behold cytometrists: one block is not enough! Cyanine-tandems bind non-specifically to human monocytes","volume":"99","author":"Kristensen","year":"2021","journal-title":"Cytometry A"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.6.2358.bloodjournal8862358","article-title":"Binding of PE-CY5 conjugates to the human high-affinity receptor for IgG (CD64) [letter; comment","volume":"88","author":"van Vugt","year":"1996","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","first-page":"102777","DOI":"10.1016\/j.xpro.2023.102777","article-title":"Development of single-cell transcriptomic atlas of human plasmacytoid dendritic cells from people with HIV-1","volume":"5","author":"Cham","year":"2024","journal-title":"STAR Protoc"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-235382","article-title":"Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion","volume":"115","author":"Jahrsd\u00f6rfer","year":"2010","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.672729","article-title":"Phenotypical diversification of early IFNalpha-producing human plasmacytoid dendritic cells using droplet-based microfluidics","volume":"12","author":"Van Eyndhoven","year":"2021","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e1005254","DOI":"10.1371\/journal.ppat.1005254","article-title":"Interferon-alpha subtypes in an ex vivo model of acute HIV-1 infection: expression, potency and effector mechanisms","volume":"11","author":"Harper","year":"2015","journal-title":"PloS Pathog"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.96101","article-title":"A type of human skin dendritic cell marked by CD5 is associated with the development of inflammatory skin disease","volume":"2","author":"Korenfeld","year":"2017","journal-title":"JCI Insight"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1126\/science.aag3009","article-title":"Mapping the human DC lineage through the integration of high-dimensional techniques","volume":"356","author":"See","year":"2017","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.immuni.2018.03.020","article-title":"Self-renewal and toll-like receptor signaling sustain exhausted plasmacytoid dendritic cells during chronic viral infection","volume":"48","author":"Macal","year":"2018","journal-title":"Immunity"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abc7302","article-title":"Human plasmacytoid dendritic cells mount a distinct antiviral response to virus-infected cells","volume":"6","author":"Yun","year":"2021","journal-title":"Sci Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/v12020162","article-title":"Regulation of transcription factor E2-2 in human plasmacytoid dendritic cells by monocyte-derived TNFalpha","volume":"12","author":"Dewald","year":"2020","journal-title":"Viruses"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230341","article-title":"Nucleotide modifications enable rational design of TLR7-selective ligands by blocking RNase cleavage","volume":"221","author":"Tong","year":"2024","journal-title":"J Exp Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041231","article-title":"The ETS transcription factor Spi-B is required for human plasmacytoid dendritic cell development","volume":"200","author":"Schotte","year":"2004","journal-title":"J Exp Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00413-x","article-title":"Genetic models of human and mouse dendritic cell development and function","volume":"21","author":"Anderson","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00866-w","article-title":"Reply to \u2018Reclassification of plasmacytoid dendritic cells as innate lymphocytes is premature\u2019","volume":"23","author":"Ziegler-Heitbrock","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41577-022-00806-0","article-title":"Reclassifying plasmacytoid dendritic cells as innate lymphocytes","volume":"23","author":"Ziegler-Heitbrock","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00864-y","article-title":"Reclassification of plasmacytoid dendritic cells as innate lymphocytes is premature","volume":"23","author":"Reizis","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.molimm.2023.05.007","article-title":"Plasmacytoid dendritic cells: A dendritic cell in disguise","volume":"159","author":"Arroyo Hornero","year":"2023","journal-title":"Mol Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1056","article-title":"Epigenetic program and transcription factor circuitry of dendritic cell development","volume":"43","author":"Lin","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"E998","DOI":"10.1073\/pnas.1319228111","article-title":"Dendritic cell fate is determined by BCL11A","volume":"111","author":"Ippolito","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.11.023","article-title":"Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells","volume":"33","author":"Ghosh","year":"2010","journal-title":"Immunity"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-370239","article-title":"The transcription factor Spi-B regulates human plasmacytoid dendritic cell survival through direct induction of the antiapoptotic gene BCL2-A1","volume":"119","author":"Karrich","year":"2012","journal-title":"Blood"},{"key":"B56","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.immuni.2020.07.003","article-title":"Differential IRF8 transcription factor requirement defines two pathways of dendritic cell development in humans","volume":"53","author":"Cytlak","year":"2020","journal-title":"Immunity"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.08.013","article-title":"IRF8 transcription factor controls survival and function of terminally differentiated conventional and plasmacytoid dendritic cells, respectively","volume":"45","author":"Sichien","year":"2016","journal-title":"Immunity"},{"key":"B58","doi-asserted-by":"publisher","first-page":"114296","DOI":"10.1016\/j.celrep.2024.114296","article-title":"Quantitative trait loci mapping provides insights into the genetic regulation of dendritic cell numbers in mouse tissues","volume":"43","author":"Oliveira","year":"2024","journal-title":"Cell Rep"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.101","article-title":"Recurrent MYB rearrangement in blastic plasmacytoid dendritic cell neoplasm","volume":"31","author":"Suzuki","year":"2017","journal-title":"Leukemia"}],"updated-by":[{"DOI":"10.3389\/fimmu.2025.1625107","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1550397\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T05:12:54Z","timestamp":1748495574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1550397\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":59,"alternative-id":["10.3389\/fimmu.2025.1550397"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1550397","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"article-number":"1550397"}}